Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 5, 2002
[Transfer to intensive care units for children with neoplasms: what decision-making tools are available?]J H DalleBone Marrow Transplantation|November 26, 2008
HSCT for Fanconi anemia in children: factors that influence early and late resultsJ-H DalleArchives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 8, 2013
[Hematopoietic stem cell transplantation in 2012: who? Where? How?]J-H DalleArchives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|March 1, 2005
[Cord blood banking: public versus private banks--facts to ponder and consider]J H DalleArchives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|October 31, 2001
[Methotrexate-ciprofloxacin interaction: report of two cases of severe intoxication]J H Dalle, A Auvrignon, G Vassal, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 29, 2013
[Dyskeratosis congenita: an update]V Mialou, T Leblanc, R Peffault de Latour, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|September 11, 2012
[Fanconi anemia in 2012: diagnosis, pediatric follow-up and treatment]J Lanneaux, A Poidvin, F Soole, et al.Bone Marrow Transplantation|July 28, 2009
Cellular immune parameters associated with spontaneous control of CMV in children who underwent transplantationV Guérin, J-H Dalle, B Pédron, et al.Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 5, 2002
[Cutaneous symptoms revealing a monoblastic leukemia]J H Dalle, L Mortier, C Roumier, et al.Bone Marrow Transplantation|October 29, 2013
Survey of CMV management in pediatric allogeneic HSCT programs, on behalf of the inborn errors, infectious diseases and pediatric diseases working parties of EBMTT Bontant, P Sedlaçek, A Balduzzi, et al.Pageof 5